Approaches for Early Identification of Abuse Potential Liability
- 14 September 2018
- book chapter
- Published by Elsevier
- p. 143-169
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Current FDA regulatory guidance on the conduct of drug discrimination studies for NDA review: Does the scientific literature support recent recommendations?Drug and Alcohol Dependence, 2016
- Effects of the δ opioid agonist AZD2327 upon operant behaviors and assessment of its potential for abusePharmacology Biochemistry and Behavior, 2014
- A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissionsJournal of Pharmacological and Toxicological Methods, 2013
- Preclinical Pharmacology of AZD2327: A Highly Selective Agonist of the δ-Opioid ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Guidelines and methodological reviews concerning drug abuse liability assessmentDrug and Alcohol Dependence, 2003
- Probes for Narcotic Receptor Mediated Phenomena. 19. Synthesis of (+)-4-[(.alpha.R)-.alpha.-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): A Highly Selective, Nonpeptide .delta. Opioid Receptor AgonistJournal of Medicinal Chemistry, 1994
- Seizures associated with recreational drug abuseNeurology, 1989
- Persistent Behavior at High Rates Maintained by Intravenous Self-Administration of NicotineScience, 1981
- FIXED‐INTERVAL SCHEDULE OF COCAINE REINFORCEMENT: EFFECT OF DOSE AND INFUSION DURATION1Journal of the Experimental Analysis of Behavior, 1973
- Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mousePsychopharmacology, 1968